Handbook of Clinical medicine

of un employment, accidents, amnesia, mood, ret ention; inconti- executive functioning. nence NB T°, malaise, nausea, vomiting, positional vertigo, seizures, aphasia, meningism, bilateral optic neuritis, CSF leucocytosis and CSF protein are rare in MS, and may suggest non-MS recurrent demyelinating disease, eg vasculitis or sarcoidosis. Diagnostic criteria for MS Table 10.9 McDonald criteria for diagnosing MS (2010) Clinical presentation Additional evidence needed for diagnosis ≥2 attacks (relapses) with ≥2 None objective clinical lesions ≥2 attacks with 1 objective clinical • MRI: spatially disseminated lesions, or • +ve CSF lesion and ≥2 MRI lesions, or • 2nd attack at a new site 1 attack with ≥2 objective clinical Dissemination in time: • new lesion on repeat MRI lesions after >3 months or • 2nd attack 1 attack with 1 objective clinical Dissemination in space: • MRI or +ve CSF if ≥2 MRI lesion (monosymptomatic pres- lesions consistent with MS • and dissemination in entation) time (by MRI or a 2nd clinical attack) Insidious neurological progression +ve CSF and dissemination in space on MRI/VEP suggestive of primary progres- or continued progression for ≥1yr sive MS A careful history may reveal past episodes, eg brief unexplained visual loss, and detailed examination may show
